English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Synthetische Letalität als Therapiekonzept für die Behandlung maligner Neoplasien

MPS-Authors
/persons/resource/persons147191

Herter-Sprie,  G. S.
Neuronal Control of Metabolism, Department Jens Brüning, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147147

Chen,  S.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147267

Reinhardt,  H. Christian
Neuronal Control of Metabolism, Department Jens Brüning, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Herter-Sprie, G. S., Chen, S., Höpker, K., & Reinhardt, H. C. (2012). Synthetische Letalität als Therapiekonzept für die Behandlung maligner Neoplasien. Tumor Diagnostik und Therapie, 33(5), 284-289. doi:10.1055/s-0032-1313078.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0026-D98F-1
Abstract
There is no abstract available